This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 May 1;157(5):383.

doi: 10.1001/jamasurg.2022.0156.

Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Epithelial Ovarian Cancer

Stephanie L Wethington¹, Deborah K Armstrong², Fabian M Johnston³

Affiliations

Affiliations

¹ Department of Gynecology and Obstetrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
³ Division of Surgical Oncology, Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

PMID: 35262650
DOI: 10.1001/jamasurg.2022.0156

Comment

Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Epithelial Ovarian Cancer

Stephanie L Wethington et al. JAMA Surg. 2022.

. 2022 May 1;157(5):383.

doi: 10.1001/jamasurg.2022.0156.

Authors

Stephanie L Wethington¹, Deborah K Armstrong², Fabian M Johnston³

Affiliations

¹ Department of Gynecology and Obstetrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
³ Division of Surgical Oncology, Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

PMID: 35262650
DOI: 10.1001/jamasurg.2022.0156

No abstract available

PubMed Disclaimer

Comment on

Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer: A Randomized Clinical Trial.
Lim MC, Chang SJ, Park B, Yoo HJ, Yoo CW, Nam BH, Park SY; HIPEC for Ovarian Cancer Collaborators. Lim MC, et al. JAMA Surg. 2022 May 1;157(5):374-383. doi: 10.1001/jamasurg.2022.0143. JAMA Surg. 2022. PMID: 35262624 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information